Ravi Mehrotra

Stock Analyst at UBS

(1.26)

# 3,368

Out of 4,786 analysts

3

Total ratings

50%

Success rate

-0.39%

Average return

Main Sectors:

Industrials Healthcare

Top Industries:

Specialty Industrial Machinery Biotechnology

Stocks Rated by Ravi Mehrotra

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	IR Ingersoll Rand	Assumes: Buy	$102 → $124	$79.44	+56.09%	1	Nov 13, 2024
	CRSP CRISPR Therapeutics AG	Downgrades: In-Line	$85 → $52	$36.99	+40.58%	2	Feb 3, 2020

Ingersoll Rand

Nov 13, 2024

Assumes: Buy

Price Target: $102 → $124

Current: $79.44

Upside: +56.09%

CRISPR Therapeutics AG

Feb 3, 2020

Downgrades: In-Line

Price Target: $85 → $52

Current: $36.99

Upside: +40.58%